Therapeutic Potential of Qilianxiaopi Formula: Targeting ADAM17-Mediated Chronic Inflammation in Atrophic Gastritis
<b>Background</b>: Gastric cancer (GC) is a leading cause of mortality worldwide, particularly in China. Chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are recognized as precancerous conditions contributing to GC development. Qilianxiaopi formula (QLXP), a traditional Ch...
Saved in:
| Main Authors: | Sijing Du, Tianxiang Wang, Zhiqiang Li, Ting Li, Zelong Miao, Yuling Chen, Songbiao Zhu, Wei Wei, Haiteng Deng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/3/435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastric Polyps and Atrophic Gastritis
by: I. Yu. Kolesnikova, et al.
Published: (2021-06-01) -
Natural Course of Atrophic Gastritis and Intestinal Metaplasia
by: Beom Jin Kim
Published: (2020-06-01) -
Changes of gastric microflora and metabolites in patients with chronic atrophic gastritis
by: Yumei Ma, et al.
Published: (2025-05-01) -
Endoscopic Diagnosis and Classification of Atrophic Gastritis and Intestinal Metaplasia
by: Seong Woo Jeon
Published: (2020-06-01) -
Optimized therapeutic potential of Sijunzi-similar formulae for chronic atrophic gastritis via Bayesian network meta-analysis
by: Meilan Huang, et al.
Published: (2024-09-01)